BANK OF AMERICA CORP /DE/
BankPosition in APLS — Apellis Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in APLS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,190,864
+24.5% QoQ
Ownership
0.930%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in APLS Over Time
Shares Held
Position Value (USD)
Derivatives in APLS
reported options exposure · as of Dec 31, 2023CallValue
$0
CallShares
84,100
PutValue
$0
PutShares
80,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in APLS
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 1,190,864 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | — | 956,773 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | — | 1,477,525 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | — | 2,426,628 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | — | 3,131,436 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | — | 1,680,213 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | — | 975,004 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | — | 995,069 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | — | 723,444 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | — | 84,100 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | — | 80,000 | Put | Defined | 2024-02-14 | |
| 2023-12-31 | — | 434,337 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | — | 704,955 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | — | 128,200 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | — | 52,700 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | — | 16,100 | Put | Defined | 2023-08-14 | |
| 2023-06-30 | — | 409,842 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | — | 607,735 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | — | 469,012 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | — | 691,877 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | — | 368,316 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | — | 381,958 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | — | 274,906 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | — | 279,972 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | — | 149,200 | Call | Defined | 2021-11-15 | |
| 2021-09-30 | — | 106,500 | Put | Defined | 2021-11-15 | |
| 2021-06-30 | — | 240,379 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | — | 357,979 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | — | 151,625 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | — | 123,944 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | — | 178,641 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | — | 213,120 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||